This finding is in line with the amplification rate of canonical oncogenes, such as EGFR, ERBB2, C-MYC, N-MYC, CCND1, MDM2, and RAS, which generally range from 10 to 30% in different tumor types [2]. This evidence concerns the gene MDM2 and neoplasm.